Wellington Management Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $677M | Sell |
2,075,752
-535,234
| -20% | -$175M | 0.12% | 160 |
|
2025
Q1 | $705M | Sell |
2,610,986
-1,585,637
| -38% | -$428M | 0.14% | 151 |
|
2024
Q4 | $988M | Sell |
4,196,623
-756,724
| -15% | -$178M | 0.18% | 122 |
|
2024
Q3 | $1.36B | Sell |
4,953,347
-1,257,132
| -20% | -$346M | 0.24% | 104 |
|
2024
Q2 | $1.51B | Sell |
6,210,479
-998,526
| -14% | -$243M | 0.27% | 90 |
|
2024
Q1 | $1.08B | Sell |
7,209,005
-5,193
| -0.1% | -$776K | 0.19% | 132 |
|
2023
Q4 | $1.38B | Buy |
7,214,198
+782,384
| +12% | +$150M | 0.26% | 98 |
|
2023
Q3 | $1.14B | Buy |
6,431,814
+364,021
| +6% | +$64.5M | 0.23% | 109 |
|
2023
Q2 | $1.15B | Sell |
6,067,793
-85,984
| -1% | -$16.3M | 0.22% | 108 |
|
2023
Q1 | $1.23B | Sell |
6,153,777
-80,309
| -1% | -$16.1M | 0.24% | 100 |
|
2022
Q4 | $1.48B | Buy |
6,234,086
+279,793
| +5% | +$66.5M | 0.3% | 88 |
|
2022
Q3 | $1.19B | Buy |
5,954,293
+141,423
| +2% | +$28.3M | 0.25% | 100 |
|
2022
Q2 | $848M | Sell |
5,812,870
-1,221,617
| -17% | -$178M | 0.17% | 130 |
|
2022
Q1 | $1.15B | Buy |
7,034,487
+190,057
| +3% | +$31M | 0.2% | 123 |
|
2021
Q4 | $1.16B | Sell |
6,844,430
-526,642
| -7% | -$89.3M | 0.19% | 124 |
|
2021
Q3 | $1.39B | Sell |
7,371,072
-1,807,417
| -20% | -$341M | 0.24% | 97 |
|
2021
Q2 | $1.56B | Buy |
9,178,489
+30,539
| +0.3% | +$5.18M | 0.26% | 96 |
|
2021
Q1 | $1.29B | Sell |
9,147,950
-908,990
| -9% | -$128M | 0.23% | 103 |
|
2020
Q4 | $1.31B | Sell |
10,056,940
-80,586
| -0.8% | -$10.5M | 0.24% | 99 |
|
2020
Q3 | $1.48B | Sell |
10,137,526
-334,201
| -3% | -$48.7M | 0.31% | 84 |
|
2020
Q2 | $1.55B | Sell |
10,471,727
-1,815,051
| -15% | -$269M | 0.35% | 70 |
|
2020
Q1 | $1.34B | Sell |
12,286,778
-1,999,696
| -14% | -$218M | 0.35% | 63 |
|
2019
Q4 | $1.65B | Sell |
14,286,474
-546,433
| -4% | -$62.9M | 0.34% | 65 |
|
2019
Q3 | $1.19B | Sell |
14,832,907
-31,061
| -0.2% | -$2.5M | 0.27% | 81 |
|
2019
Q2 | $1.08B | Buy |
14,863,968
+31,370
| +0.2% | +$2.28M | 0.24% | 99 |
|
2019
Q1 | $1.39B | Buy |
14,832,598
+766,371
| +5% | +$71.6M | 0.31% | 76 |
|
2018
Q4 | $1.03B | Buy |
14,066,227
+1,034,915
| +8% | +$75.5M | 0.26% | 96 |
|
2018
Q3 | $1.14B | Buy |
13,031,312
+1,246,992
| +11% | +$109M | 0.24% | 107 |
|
2018
Q2 | $1.16B | Buy |
11,784,320
+2,181,158
| +23% | +$215M | 0.26% | 100 |
|
2018
Q1 | $1.14B | Buy |
9,603,162
+420,632
| +5% | +$50.1M | 0.26% | 97 |
|
2017
Q4 | $1.17B | Sell |
9,182,530
-2,118,787
| -19% | -$269M | 0.26% | 92 |
|
2017
Q3 | $1.33B | Sell |
11,301,317
-567,731
| -5% | -$66.7M | 0.3% | 86 |
|
2017
Q2 | $947M | Sell |
11,869,048
-172,131
| -1% | -$13.7M | 0.22% | 110 |
|
2017
Q1 | $617M | Buy |
12,041,179
+31,208
| +0.3% | +$1.6M | 0.15% | 163 |
|
2016
Q4 | $450M | Buy |
12,009,971
+12,492
| +0.1% | +$468K | 0.11% | 186 |
|
2016
Q3 | $813M | Buy |
11,997,479
+25,696
| +0.2% | +$1.74M | 0.2% | 118 |
|
2016
Q2 | $664M | Buy |
11,971,783
+26,176
| +0.2% | +$1.45M | 0.17% | 138 |
|
2016
Q1 | $750M | Buy |
11,945,607
+1,288,123
| +12% | +$80.9M | 0.2% | 120 |
|
2015
Q4 | $1B | Buy |
10,657,484
+333,358
| +3% | +$31.4M | 0.26% | 91 |
|
2015
Q3 | $830M | Buy |
10,324,126
+710,086
| +7% | +$57.1M | 0.23% | 105 |
|
2015
Q2 | $1.15B | Sell |
9,614,040
-826,774
| -8% | -$99.1M | 0.3% | 78 |
|
2015
Q1 | $1.09B | Buy |
10,440,814
+1,493,678
| +17% | +$156M | 0.28% | 84 |
|
2014
Q4 | $868M | Sell |
8,947,136
-509,985
| -5% | -$49.5M | 0.23% | 97 |
|
2014
Q3 | $739M | Buy |
9,457,121
+325,004
| +4% | +$25.4M | 0.2% | 108 |
|
2014
Q2 | $577M | Buy |
9,132,117
+1,087,573
| +14% | +$68.7M | 0.16% | 144 |
|
2014
Q1 | $540M | Sell |
8,044,544
-103,332
| -1% | -$6.94M | 0.15% | 151 |
|
2013
Q4 | $524M | Buy |
8,147,876
+6,085,029
| +295% | +$391M | 0.15% | 156 |
|
2013
Q3 | $132M | Buy |
+2,062,847
| New | +$132M | 0.04% | 421 |
|